PreCanCell:一个集体学习算法,用于从单细胞转录组中预测癌症和非癌症细胞
Tao Yang1,2,3, Qiyu Yan1,2,3, Rongzhuo Long1,2,3
1Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Computational and structural biotechnology journal
|July 28, 2023
概括
PreCanCell使用差异表达基因准确地预测来自单细胞转录组的恶性和非恶性细胞. 与现有方法相比,这种新的算法提供了更高的准确性和更简单的实现.
科学领域:
- 计算生物学 计算生物学
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 单细胞RNA测序 (scRNA-seq) 能够对瘤中的细胞异质性进行高分辨率分析.
- 区分恶性细胞和非恶性细胞对于理解癌症进展和开发向疗法至关重要.
- 目前用于细胞类型分类的计算工具在不同癌症类型的准确性或适用性上可能存在局限性.
研究的目的:
- 开发和验证一种新的算法PreCanCell,用于从单细胞转录组中准确预测恶性和非恶性细胞.
- 在多种癌症类型中识别常见的差异表达基因 (DEG),以进行强大的细胞分类.
- 将PreCanCell的性能与已建立的算法进行比较.
主要方法:
- 在五种癌症类型 (RCC,HNSCC,黑色素瘤,LUAD,BC) 中识别恶性和非恶性细胞之间的常见DEG.
- 使用k-最近邻居 (k-NN) 模型 (k=5) 训练每个癌症类型的DEG,对单个细胞进行分类.
- 通过五个独立的k-NN分类器的大多数投票预测最终细胞的确定.
主要成果:
- 在19个独立的单细胞数据集中,PreCanCell实现了高预测性能,精度,灵敏度,特异性,平衡精度和AUROC始终高于0.8.8.
- 与其他七种领先的计算方法 (CHETAH,SciBet,SCINA,scmap-cell,scmap-cluster,SingleR,ikarus) 相比,该算法显示出更高的准确性和更简单的实现.
结论:
- PreCanCell是一个强大而准确的算法,用于在单细胞转录基因数据中区分恶性和非恶性细胞.
- 该方法在各种癌症类型中的有效性及其比较优势使其成为癌症研究的宝贵工具.
- 为PreCanCell提供了一个R包,促进其在科学界更广泛的应用.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


